Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaPRADOS, Michael D; CHANG, Susan M; FEDOROFF, Anne et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 579-584, issn 0732-183X, 6 p.Article

Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenograftsD'ASSORO, Antonino B; LEONTOVICH, Alexey; GALANIS, Evanthia et al.International journal of oncology. 2010, Vol 37, Num 5, pp 1167-1176, issn 1019-6439, 10 p.Article